文献速递前列腺癌

MRI阴性前列腺癌的患者与肿瘤层面危险因素

Patient- and tumor-level risk factors for MRI-invisible prostate cancer.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2021-02-10

本研究回顾2015至2018年194例接受MRI/超声融合靶向+系统穿刺的男性,定义MRI阴性肿瘤为无MRI病灶区域系统穿刺阳性。多变量分析显示黑人种族与GG1+ MRI阴性肿瘤相关(OR 2.2,95%CI 1.02-4.96),黑人种族(OR 3.5,95%CI 1.24-9.87)和更高PSA密度(OR 2.0,95%CI 1.34-3.20)与GG2+ MRI阴性肿瘤相关。结论提示黑人种族和PSA密度是MRI阴性前列腺癌的预测因素,决定省略系统穿刺前应考虑术前危险因素。

要点

  • 黑人种族与GG1+ MRI阴性肿瘤独立相关(OR 2.2)。
  • 黑人种族和更高PSA密度与GG2+ MRI阴性肿瘤相关。
  • 系统穿刺可因MRI阴性肿瘤将部分患者升级为GG2+疾病。

核心结论

  • 黑人种族和PSA密度与MRI阴性前列腺癌的存在相关。

研究设计与样本

  • 回顾性分析194例2015至2018年在本机构由两位术者行MRI/超声融合靶向+系统穿刺的男性。

主要发现

  • 79例(41%)和25例(13%)男性分别存在GG1+和GG2+ MRI阴性肿瘤。
  • 多变量分析中仅黑人种族与GG1+ MRI阴性肿瘤相关(OR 2.2,95%CI 1.02-4.96)。
  • 黑人种族(OR 3.5,95%CI 1.24-9.87)和更高PSA密度(OR 2.0,95%CI 1.34-3.20)与GG2+ MRI阴性肿瘤相关。
  • 非黑人和黑人男性中,系统穿刺检出MRI阴性肿瘤使无病患者升级为GG2+的比例分别为1%和11%,使GG1患者升级为GG2+的比例分别为42%和60%。

临床怎么用

  • 决定省略系统前列腺穿刺时,无论mpMRI结果如何,术者应考虑术前危险因素。

局限性

  • 基于这些结果,有必要进一步研究种族差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Multiparametric MRI is highly sensitive for detection of clinically significant prostate cancer, but has a 10-20% false negative rate. It is unknown if there are clinical factors that predict MRI invisibility. We sought to identify predictors of MRI-invisible (MRI(-)) disease. METHODS: Men undergoing MRI/US-fusion targeted + systematic biopsy by two surgeons at our institution from 2015 to 2018 were reviewed. Patient demographics, clinical data, MRI metrics, and biopsy pathology results were obtained by chart review. An MRI(-) tumor was defined as a positive systematic biopsy in a zone without an MRI lesion. Factors associated with presence of MRI(-) tumors were identified using stepwise multivariable logistic regression. RESULTS: Of 194 men included in the analysis, 79 (41%) and 25 (13%) men had GG1+ and GG2+ MRI(-) tumors, respectively. On multivariable analysis, only Black race was associated with presence of GG1+ MRI(-) tumors (OR 2.2, 95% CI 1.02-4.96). Black race (OR 3.5, 95% CI 1.24-9.87) and higher PSA density (OR 2.0, 95% CI 1.34-3.20) were associated with presence of GG2+ MRI(-) tumors. In non-Black and Black men, detection of MRI(-) tumors on systematic biopsy upgraded patients from no disease to GG2+ disease 1% and 11% of the time, respectively, and from GG1 to GG2+ disease 42% and 60% of the time, respectively. CONCLUSIONS: Black race and PSA density were associated with presence of MRI(-) prostate cancer. Further study on racial differences is warranted based on these results. Surgeons should consider pre-biopsy risk factors before deciding to omit systematic prostate biopsy regardless of mpMRI results.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Kuhlmann PK, Chen M, Luu M, et al. Patient- and tumor-level risk factors for MRI-invisible prostate cancer. Prostate Cancer Prostatic Dis. 2021. PMID: 33568751. doi:10.1038/s41391-021-00330-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。